You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB0450 Effect of adalimumab discontinuation on patient-reported outcomes and work productivity in early rheumatoid arthritis patients who achieved low disease activity following 26 weeks of treatment: Data from the optima study

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
Rheumatoid arthritis – anti-TNF therapy
AB0450 Effect of adalimumab discontinuation on patient-reported outcomes and work productivity in early rheumatoid arthritis patients who achieved low disease activity following 26 weeks of treatment: Data from the optima study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Kavanaugh A, Emery P, van Vollenhoven R, et al
AB0450 Effect of adalimumab discontinuation on patient-reported outcomes and work productivity in early rheumatoid arthritis patients who achieved low disease activity following 26 weeks of treatment: Data from the optima study
Annals of the Rheumatic Diseases 2013;71:663.